Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2022 and Recent Developments
September 06, 2022 16:05 ET
|
Avid Bioservices, Inc
-- Recorded First Quarter Revenue of $36.7 Million -- -- Signed $41 Million in Net New Business Orders and Ended the Quarter with a Record High Backlog of $157 Million -- -- Facilities and...
Biotimize Announces the Opening of a Fundraising Round to Build the First Biological CDMO in Brazil
September 05, 2022 08:30 ET
|
Biotimize - Biotechnology as a Service
PIRACICABA, Brazil, Sept. 05, 2022 (GLOBE NEWSWIRE) -- Biotimize, a functional growth-stage biotechnology as a service (BaaS) company with a mission to transform lives through biotechnology, today...
Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2023 After Market Close on September 6, 2022
August 30, 2022 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Pharmaceutical Aseptic Transfer Global Market Report 2022: Liquid Aseptic Transfer Systems Gaining Traction and Presenting Opportunities
August 30, 2022 04:38 ET
|
Research and Markets
Dublin, Aug. 30, 2022 (GLOBE NEWSWIRE) -- The "Pharmaceutical Aseptic Transfer Market - A Global and Regional Analysis: Focus on System Transfer, Transfer Type, Usability, End User, and Region -...
Rentschler Biopharma appoints Mark Caswell as Vice President, Site Head for US Facility
August 18, 2022 09:03 ET
|
Rentschler Biopharma SE
LAUPHEIM, Germany and MILFORD, Mass., Aug. 18, 2022 (GLOBE NEWSWIRE) -- Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals,...
Societal CDMO Announces Signing of More Than $9 Million Sales and Purchase Agreement With David Weekley Homes for Excess Lakefront Land
August 16, 2022 07:00 ET
|
Societal CDMO, Inc.
Established Homebuilder to Purchase Approximately 121 Acres in Gainesville, Georgia, for Residential Development Proceeds from Sale to Strengthen Societal CDMO’s Corporate Balance Sheet Through...
Societal CDMO Reports Second Quarter 2022 Financial Results
August 10, 2022 16:05 ET
|
Societal CDMO, Inc.
Recorded Q2 Revenue of $23.2 Million, a 29% Increase Compared to Prior Year Period Signed Multiple New Business Agreements Spanning Clinical Trial Support, Commercial Manufacturing and Packaging ...
Societal CDMO Adds Three New Customers, Signing Agreements to Provide CDMO Services Supporting Clinical Development of Several Novel Therapeutic Candidates
August 04, 2022 07:00 ET
|
Societal CDMO, Inc.
Contracted Activities Touch Upon Broad Range of Societal’s Offerings from Clinical Trial Services to Formulation Development to cGMP Manufacturing Work to be Conducted Collaboratively at Societal’s...
Societal CDMO to Report Financial Results for Second Quarter 2022 on August 10, 2022
August 03, 2022 16:05 ET
|
Societal CDMO, Inc.
SAN DIEGO, Calif. and GAINESVILLE, Ga., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL), a contract development and manufacturing organization...
Global Pharmaceutical Isolators Market Report 2022: Increase in Use of High-potency Active Pharmaceutical Ingredients Driving Growth
July 26, 2022 06:58 ET
|
Research and Markets
Dublin, July 26, 2022 (GLOBE NEWSWIRE) -- The "Global Pharmaceutical Isolators Market (High-value & Low-value): Insights & Forecast with Potential Impact of COVID-19 (2022-2026)" report has...